P3 Health Partners | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 386.38 M

Revenue: As of FY2026 Q2, the actual value is USD 386.38 M, beating the estimate of USD 377.8 M.

EPS: As of FY2026 Q2, the actual value is USD -0.63, beating the estimate of USD -1.895.

EBIT: As of FY2026 Q2, the actual value is USD 26.04 M.

The provided reference, a Form 8-K filing by P3 Health Partners Inc., indicates that the company announced its financial results for the three and six months ended June 30, 2026, on August 10, 2026. However, the full text of the press release containing these financial results is furnished as Exhibit 99.1 to the report and is not included in the provided reference material. Therefore, no specific financial or operational metrics, including segment revenue, net income, gross margin, operating profit, operating margin, operating costs, cash flow (operating or free), or company-specific indicators, can be extracted from the given text. Additionally, the reference does not contain any outlook or guidance statements.